DOCOMO to Exhibit at MWC Barcelona 2025, World's Largest Connectivity Exhibition
24.1.2025 06:01:00 CET | Business Wire | Press release
NTT DOCOMO, INC. announced today that it will exhibit at MWC Barcelona 2025, the world's largest connectivity exhibition, in Barcelona, Spain from March 3 to 6. DOCOMO and its parent NTT Group will showcase technologies and initiatives focused on the core themes of non-terrestrial networks (NTN) and aerospace, open radio access networks (Open RAN), and entertainment, aiming to promote international standardization and new business focused on next-generation communication technologies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250123714093/en/
NTT DOCOMO Booth at MWC Barcelona 2025 (Graphic: Business Wire)
DOCOMO is developing cutting-edge technologies and businesses under its brand slogan “Bridging Worlds for Wonder & Happiness.”
In the NTN and aerospace field, DOCOMO will highlight its latest initiatives under the NTT Group’s “NTT C89” space-business strategy, such as mobile-connectivity services using unmanned vehicles, or high-altitude platform stations (HAPS), that fly in the stratosphere for days or months, using relays to provide mobile connectivity in mountainous and remote areas, including at sea and in the sky.
For Open RAN, DOCOMO will showcase collaborations with global telecom operators, and also Open RAN services that leverage the strengths of various global partners, offered by OREX SAI, INC., a joint venture with NEC.
In the entertainment field, DOCOMO will display MiRZA® XR glasses by NTT QONOQ Devices, Inc., designed for diverse use cases including enterprise solutions, including a touch-and-try demonstration of the NTT XR Real Support solution for remote work enabled by XR glasses. A commercial prototype of AR glasses, which are scheduled to be released from this summer onwards, will also be on display (final specifications may vary).
Additionally, DOCOMO will showcase FEEL TECH®,an innovative technology that transforms how sensory information are shared, tailoring to the other person’s unique perception. Through a demonstration that conveys the emotions and sensations of characters alongside visuals and sound, visitors will have the opportunity to experience DOCOMO’s vision for the future of entertainment.
DOCOMO will also showcase the Virtual EXPO of Expo 2025 primarily developed by NTT QONOQ, INC. aiming for a service launch in April. This virtual site allows visitors to experience the NTT Pavilion using various devices.
DOCOMO’s booth at MWC Barcelona 2025 will be located at Stand 4E50 in Hall 4. During the exhibition, Mr. Sadayuki Abeta, Chief Open RAN Strategist at NTT DOCOMO and Chief Technology Officer at OREX SAI, will give a presentation on his company’s latest initiatives, case histories and future plans at the MWC Broadcast Stage 2025 in Hall 4 on Tuesday, March 4 from 16:15 to 16:45 (please see MWC Barcelona 2025 website to confirm final content and schedule).
About MWC Barcelona 2025
https://www.mwcbarcelona.com/
When:
March 3 to 6
08:30 to 19:00 (16:00 on last day)
Where:
Fira Gran Via
Av. Joan Carles I, 64
08908 L'Hospitalet de Llobregat
Barcelona, Spain
NTT C89 is pending trademark registration.
MiRZA® is a registered trademark of NTT QONOQ Devices, Inc. in Japan.
FEEL TECH® is a registered trademark of NTT DOCOMO, INC. in Japan
About NTT DOCOMO
NTT DOCOMO, Japan's leading mobile operator with over 89 million subscribers, is one of the global leaders in 3G, 4G and 5G mobile network technologies.
Under the slogan "Bridging Worlds for Wonder & Happiness," DOCOMO is actively collaborating with global partners to expand its business scope from mobile services to comprehensive solutions, aiming to deliver unsurpassed value and drive innovation in technology and communications, ultimately to support positive change and advancement in global society.
https://www.docomo.ne.jp/english/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250123714093/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom